Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Trading Update - Improved Outlook

21 May 2021 07:00

RNS Number : 3603Z
Gattaca PLC
21 May 2021
 

21 May 2021

Gattaca plc

 

Trading Update - Improved Outlook

 

("Gattaca", the "Group" or "the Company")

 

Gattaca plc, the specialist Engineering and Technology recruitment solutions business, today issues a trading update for FY ending 31 July 2021.

 

Since we announced our half year results on 31 March we have seen a faster rate of recovery in NFI than originally expected. In Q3 we are pleased to have delivered quarter-on-quarter UK NFI growth of 13% across a broad range of segments. In addition, the changes arising from the introduction of new tax legislation (IR35) had less of an impact on the Company than we anticipated. We now expect NFI in H2 to be in the order of 10% up on H1 2021. We are continuing our successful recruitment drive and making targeted investment in sales and delivery headcount, whilst closely managing our cost base. Our Global technology platform, providing the Group with a fully integrated and flexible centralised system, was launched successfully in the U.K. during April.

 

Whilst there remains uncertainty around Covid-19, our current expectation is that this rate of recovery will continue, and we therefore expect our underlying continuing profit before tax for the year to 31 July 2021 will be significantly ahead of market expectations.

 

In light of the improved performance and assuming a continuation of the current positive trends, the Board anticipates the recommendation of a modest dividend when the full year results are announced.

 

Kevin Freeguard, CEO commented:

 

"We are pleased with our Q3 performance. Our people are capitalising on the opportunities to move us at pace as we grow beyond the pandemic. The strategy and focus on STEM skills and Contract staffing is serving us well and we are seeing improved underlying activity across our core markets, including Infrastructure and Defence."

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

 

Salar Farzad, Chief Financial Officer

 

 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

 

Robert Morton

 

Euan Brown

 

 

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Toby Mountford

 

Jos Bieneman

 

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVDEEIIFIL
Date   Source Headline
14th May 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 20267:00 amRNSInterim Results
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Feb 20267:00 amRNSTrading Update
31st Dec 20257:00 amRNSDirector/PDMR dealing
31st Dec 20257:00 amRNSDirector/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
16th Dec 202512:19 pmRNSExercise of Options and Director/PDMR Shareholding
11th Dec 20259:05 amRNSResults of Annual General Meeting
10th Nov 20257:00 amRNSAvailability of Report & Accounts and AGM Notice
23rd Oct 20257:00 amRNSFinal results for the year ended 31 July 2025
15th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Oct 20252:59 pmRNSBlock Listing Six Monthly return
8th Oct 20257:00 amRNSNotice of Results
5th Aug 20257:00 amRNSTrading update and Acquisition
22nd Jul 20257:00 amRNSEBT Share Purchase Programme
21st Jul 20256:22 pmRNSExercise of Options and Director/PDMR Shareholding
2nd Apr 20252:21 pmRNSCORRECTION – Interim Results
2nd Apr 20257:00 amRNSInterim Results
1st Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Feb 20257:00 amRNSTrading Update
27th Jan 20254:51 pmRNSFurther re EBT Share Purchase Programme
11th Dec 20243:59 pmRNSDirector/PDMR Shareholding
11th Dec 20242:25 pmRNSResult of AGM
11th Nov 20242:29 pmRNSAvailability of Report & Accounts and AGM Notice
30th Oct 20247:00 amRNSEBT Share Purchase Programme
24th Oct 20247:00 amRNSFinal results for the year ended 31 July 2024
1st Oct 20247:00 amRNSBlock listing Six Monthly Return
15th Aug 20247:00 amRNSTrading Update for the year ended 31 July 2024
16th Jul 202410:36 amRNSDirector/PDMR Share Purchase
11th Jul 202411:13 amRNSExercise of Options
1st Jul 20247:00 amRNSNominated Adviser and Broker
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.